Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies
Clinical trial NCT03076437 · COMPLETED
Trial details
- NCT number
- NCT03076437
- Sponsor
- Shenzhen Institute for Innovation and Translational Medicine
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-15
- Primary completion
- 2019-05-26
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.